Bison Wealth LLC Cuts Stock Position in The Clorox Company (NYSE:CLX)

Bison Wealth LLC lessened its holdings in The Clorox Company (NYSE:CLX) by 3.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 4,507 shares of the company’s stock after selling 155 shares during the period. Bison Wealth LLC’s holdings in Clorox were worth $643,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. American Century Companies Inc. grew its position in shares of Clorox by 18.0% during the first quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after purchasing an additional 1,269 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of Clorox by 6.8% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock valued at $2,289,000 after purchasing an additional 1,044 shares in the last quarter. Cibc World Market Inc. grew its position in shares of Clorox by 276.6% during the first quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock valued at $1,295,000 after purchasing an additional 6,844 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Clorox by 0.8% during the first quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock valued at $95,073,000 after purchasing an additional 5,145 shares in the last quarter. Finally, Blair William & Co. IL grew its position in shares of Clorox by 81.1% during the first quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock valued at $3,410,000 after purchasing an additional 10,981 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.0 %

Shares of NYSE CLX opened at $140.53 on Tuesday. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The company has a market cap of $17.44 billion, a P/E ratio of 223.07, a PEG ratio of 2.21 and a beta of 0.43. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21. The firm has a 50-day simple moving average of $150.92 and a two-hundred day simple moving average of $141.60.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.98 earnings per share. Research analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a dividend yield of 3.42%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is presently 761.92%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Barclays cut their price objective on Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research report on Wednesday, April 10th. UBS Group raised their price objective on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, February 2nd. The Goldman Sachs Group started coverage on shares of Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price target for the company. Citigroup lowered their price target on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a report on Tuesday. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $148.50.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.